Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Fsd Pharma Inc Cl B (HUGE)

Fsd Pharma Inc Cl B (HUGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,607
  • Shares Outstanding, K 40,117
  • Annual Sales, $ 0 K
  • Annual Income, $ -17,900 K
  • EBIT $ -15 M
  • EBITDA $ -12 M
  • 60-Month Beta 0.60
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.35
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.26
  • Most Recent Earnings $-0.05 on 05/14/24
  • Next Earnings Date 08/15/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.03
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0720 +24.86%
on 08/08/24
0.3663 -75.46%
on 08/09/24
-0.0531 (-37.13%)
since 07/12/24
3-Month
0.0720 +24.86%
on 08/08/24
0.3809 -76.40%
on 05/28/24
-0.2581 (-74.17%)
since 05/14/24
52-Week
0.0720 +24.86%
on 08/08/24
1.6799 -94.65%
on 09/18/23
-1.3101 (-93.58%)
since 08/14/23

Most Recent Stories

More News
Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price

TORONTO, ON / ACCESSWIRE / November 25, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) (the "Company") formerly named FSD Pharma Inc. (Nasdaq:HUGE)(CSE:HUGE) is pleased to follow up on...

QNTM : 3.00 (-13.29%)
QNTM.CN : 4.2100 (-19.81%)
HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)
Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price

TORONTO, ON / ACCESSWIRE / November 25, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) (the "Company") formerly named FSD Pharma Inc. (Nasdaq:HUGE)(CSE:HUGE) is pleased to follow up on...

QNTM : 3.00 (-13.29%)
QNTM.CN : 4.2100 (-19.81%)
HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)
FSD Pharma Completes Name Change to Quantum BioPharma and 65:1 Consolidation - Trading Under New Ticker Symbol "QNTM"

Toronto, Ontario--(Newsfile Corp. - August 15, 2024) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) ("Quantum BioPharma" or the "Company"), formerly FSD Pharma Inc., a biopharmaceutical company dedicated...

HUGE : 5.8435 (-10.10%)
QNTM : 3.00 (-13.29%)
HUGE.CN : 0.1250 (-13.79%)
QNTM.CN : 4.2100 (-19.81%)
FSD Pharma Announces Share Consolidation and Name Change

Toronto, Ontario--(Newsfile Corp. - August 9, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio...

HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)
24/7 Market News Publishes Report Covering Functional Beverage Market, Featuring FSD Pharma

Denver, Colorado--(Newsfile Corp. - July 25, 2024) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, today publishes a news report...

HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)
FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders

Toronto, Ontario--(Newsfile Corp. - July 23, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio...

HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)
24/7 Market News Publishes Report Covering Biotech Developments, Featuring FSD Pharma

Denver, Colorado--(Newsfile Corp. - July 23, 2024) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, today publishes a news report...

HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)
FSD Pharma Files Amended and Restated Material Change Report

Toronto, Ontario--(Newsfile Corp. - July 4, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio...

HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)
FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Toronto, Ontario--(Newsfile Corp. - April 7, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio...

HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)
DR. RAZA BOKHARI, FORMER EXECUTIVE CHAIRMAN AND CEO OF FSD PHARMA, FILES TWO ADDITIONAL CLAIMS AGAINST THE COMPANY SEEKING RELIEF AND MONETARY DAMAGES EXCEEDING $30.2 MILLION

/PRNewswire/ -- Attorneys for Dr. Raza Bokhari, the former CEO and Executive Chairman of FSD Pharma (CSE: HUGE, NASDAQ: HUGE) have filed two new claims against...

HUGE : 5.8435 (-10.10%)

Business Summary

FSD Pharma Inc. produces medical cannabis primarily in Canada. The company focuses on the development of indoor pharmaceutical grade cannabis; research and development of cannabinoid-based treatments for central nervous system disorders. FSD Pharma Inc. is based in Seattle, Washington.

See More

Key Turning Points

3rd Resistance Point 0.1176
2nd Resistance Point 0.1109
1st Resistance Point 0.1004
Last Price 5.8435
1st Support Level 0.0832
2nd Support Level 0.0765
3rd Support Level 0.0660

See More

Last Price 5.8435
52-Week High 1.6799
Fibonacci 61.8% 1.0657
Fibonacci 50% 0.8760
Fibonacci 38.2% 0.6862
52-Week Low 0.0720

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar